Stock comparison
IDEXX Laboratories
UnitedHealth
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
IDXX
IDEXX Laboratories
Market cap
$44.12B
Sector
Healthcare
UNH
UnitedHealth
Market cap
$352.79B
Sector
Healthcare
Overall winner
IDEXX Laboratories IDXX
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | IDXX | UNH | Winner |
|---|---|---|---|
| Warren Buffett | 75B | 44D | IDXX |
| Benjamin Graham | 80A | 67B | IDXX |
| Philip Fisher | 75B | 29F | IDXX |
| Peter Lynch | 71B | 23F | IDXX |
| Joel Greenblatt | 83C | 37D | IDXX |
| Charlie Munger | 87A | 36D | IDXX |
| Terry Smith | 84A | 39D | IDXX |
Side-by-side metrics
| Metric | IDXX | UNH |
|---|---|---|
| Market cap | $44.12B | $352.79B |
| P/E (TTM) | 39.0x | 29.0x |
| EV/EBIT | 31.6x | 21.0x |
| ROIC (TTM) | 40.66% | 8.09% |
| Gross margin | 62.05% | 18.8% |
| Net margin | 24.63% | 2.68% |
| Revenue CAGR 5y | 7.56% | 11.69% |
| EPS CAGR 5y | 10.79% | -7.83% |
| Debt / Equity | 0.7x | 0.7x |
| Dividend yield | 0.0% | 2.3% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
IDXX leads on
- EPS CAGR 5y10.79%vs -7.83%+173%
- Net margin24.63%vs 2.68%+89%
- ROIC (TTM)40.66%vs 8.09%+80%
- Gross margin62.05%vs 18.8%+70%
UNH leads on
- Dividend yield2.3%vs 0.0%+100%
- Market cap$352.79Bvs $44.12B+87%
- Revenue CAGR 5y11.69%vs 7.56%+35%
- EV/EBIT21.0xvs 31.6x+34%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.